Gabelli Funds LLC Sells 2,300 Shares of Teladoc Health, Inc. (NYSE:TDOC)

Gabelli Funds LLC reduced its position in Teladoc Health, Inc. (NYSE:TDOCFree Report) by 9.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 20,870 shares of the health services provider’s stock after selling 2,300 shares during the period. Gabelli Funds LLC’s holdings in Teladoc Health were worth $450,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the company. Parallel Advisors LLC lifted its holdings in shares of Teladoc Health by 14.6% in the 4th quarter. Parallel Advisors LLC now owns 4,038 shares of the health services provider’s stock worth $87,000 after purchasing an additional 515 shares in the last quarter. M&T Bank Corp lifted its holdings in shares of Teladoc Health by 5.5% in the 4th quarter. M&T Bank Corp now owns 11,152 shares of the health services provider’s stock worth $241,000 after purchasing an additional 584 shares in the last quarter. Van ECK Associates Corp lifted its holdings in shares of Teladoc Health by 20.3% in the 4th quarter. Van ECK Associates Corp now owns 3,589 shares of the health services provider’s stock worth $77,000 after purchasing an additional 606 shares in the last quarter. Victory Capital Management Inc. lifted its holdings in shares of Teladoc Health by 4.3% in the 3rd quarter. Victory Capital Management Inc. now owns 17,946 shares of the health services provider’s stock worth $334,000 after purchasing an additional 748 shares in the last quarter. Finally, Principal Financial Group Inc. lifted its holdings in shares of Teladoc Health by 7.4% in the 3rd quarter. Principal Financial Group Inc. now owns 12,774 shares of the health services provider’s stock worth $237,000 after purchasing an additional 883 shares in the last quarter. 76.82% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on TDOC shares. Citigroup cut their target price on Teladoc Health from $21.00 to $19.00 and set a “neutral” rating on the stock in a report on Wednesday, February 21st. Cantor Fitzgerald began coverage on Teladoc Health in a research report on Thursday, February 29th. They issued an “overweight” rating and a $22.00 price target for the company. Stifel Nicolaus lowered their price target on Teladoc Health from $21.00 to $16.00 and set a “hold” rating for the company in a research report on Friday, April 26th. Piper Sandler lowered their price target on Teladoc Health from $30.00 to $25.00 and set an “overweight” rating for the company in a research report on Wednesday, February 21st. Finally, Royal Bank of Canada lowered their price target on Teladoc Health from $25.00 to $18.00 and set an “outperform” rating for the company in a research report on Friday, April 26th. Thirteen equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $18.22.

View Our Latest Analysis on Teladoc Health

Teladoc Health Stock Performance

Shares of TDOC opened at $10.66 on Tuesday. The business has a 50-day moving average of $12.78 and a 200 day moving average of $16.61. Teladoc Health, Inc. has a fifty-two week low of $10.42 and a fifty-two week high of $30.41. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.82 and a quick ratio of 3.74.

Teladoc Health (NYSE:TDOCGet Free Report) last announced its quarterly earnings data on Thursday, April 25th. The health services provider reported ($0.49) earnings per share for the quarter, missing the consensus estimate of ($0.47) by ($0.02). Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.90%. The firm had revenue of $646.13 million during the quarter, compared to analysts’ expectations of $637.31 million. During the same period last year, the business posted ($0.37) EPS. The company’s revenue was up 2.7% compared to the same quarter last year. Analysts forecast that Teladoc Health, Inc. will post -1.05 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, COO Michael Willem Waters sold 5,793 shares of Teladoc Health stock in a transaction dated Thursday, May 2nd. The stock was sold at an average price of $12.69, for a total value of $73,513.17. Following the completion of the sale, the chief operating officer now owns 64,881 shares of the company’s stock, valued at approximately $823,339.89. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other Teladoc Health news, COO Michael Willem Waters sold 5,793 shares of the firm’s stock in a transaction dated Thursday, May 2nd. The stock was sold at an average price of $12.69, for a total value of $73,513.17. Following the completion of the transaction, the chief operating officer now owns 64,881 shares in the company, valued at approximately $823,339.89. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Karen L. Daniel sold 9,834 shares of the firm’s stock in a transaction dated Thursday, May 23rd. The stock was sold at an average price of $11.90, for a total value of $117,024.60. Following the completion of the transaction, the director now owns 36,995 shares of the company’s stock, valued at approximately $440,240.50. The disclosure for this sale can be found here. In the last 90 days, insiders sold 40,650 shares of company stock valued at $521,043. 0.95% of the stock is owned by insiders.

About Teladoc Health

(Free Report)

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

See Also

Institutional Ownership by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.